HRG and ovarian carcinoma: An autocrine signal-transducing loop involving ErbB3 and its activating ligand HRG has been found to promote cell proliferation in human ovarian cancer cells and the effects of HRG/ErbB3 were abrogated by genetic or pharmacological ErbB3 inhibition7.